EAM
Exome Asset Management Portfolio holdings
AUM
$110M
This Quarter Return
-6.4%
1 Year Return
+24.83%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$112M
AUM Growth
-$21.3M
(-16%)
Cap. Flow
-$14.9M
Cap. Flow
% of AUM
-13.34%
Top 10 Holdings %
Top 10 Hldgs %
39.5%
Holding
78
New
15
Increased
14
Reduced
14
Closed
24
Top Buys
| 1 |
AstraZeneca
AZN
|
$4.73M |
| 2 |
Cogent Biosciences
COGT
|
$3.72M |
| 3 |
Viridian Therapeutics
VRDN
|
$2.93M |
| 4 |
Regenxbio
RGNX
|
$2.9M |
| 5 |
Dyne Therapeutics
DYN
|
$2.7M |
Top Sells
| 1 |
Humana
HUM
|
$4.58M |
| 2 |
Relay Therapeutics
RLAY
|
$4.46M |
| 3 |
Apellis Pharmaceuticals
APLS
|
$3.81M |
| 4 |
Bristol-Myers Squibb
BMY
|
$3.69M |
| 5 |
Boston Scientific
BSX
|
$3.62M |
Sector Composition
| 1 | Healthcare | 98.64% |
